Author

Julie Chaumont

Observed institution: Program for Appropriate Technology in Health

OpenAlex ID: A5042701032

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

2011 · Samba O. Sow, Brown J. Okoko, et al. · New England Journal of Medicine · 178

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years

2015 · Aldiouma Diallo, Samba O. Sow, et al. · Clinical Infectious Diseases · 23

Conducting vaccine clinical trials in sub-Saharan Africa: Operational challenges and lessons learned from the Meningitis Vaccine Project

2012 · Elisa Marchetti, Véronique Mazarin-Diop, et al. · Vaccine · 22

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age

2015 · Milagritos D. Tapia, Helen Findlow, et al. · Clinical Infectious Diseases · 17

Meningococcal Group C and W135 Immunological Hyporesponsiveness in African Toddlers

2011 · Helen Findlow, Samba Sow, et al. · Clinical and Vaccine Immunology · 13

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine

2015 · Lionel Martellet, Samba O. Sow, et al. · Clinical Infectious Diseases · 12

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians

2015 · Milagritos D. Tapia, Samba O. Sow, et al. · Clinical Infectious Diseases · 6

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons

2015 · Godwin C. Enwere, Gandhali Paranjape, et al. · Clinical Infectious Diseases · 3

Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers

2025 · Abraham Hodgson, Fadima Cheick Haidara, et al. · Vaccine

Works count: 9

Citation count: 274

H-index: 6

I10-index: 6